Abstract
Ninety clinical isolates of Pseudomonas aeruginosa were examined for susceptibility to carbenicillin by the broth dilution and disc diffusion methods. Inhibition zone diameters varied at given minimal inhibitory concentration levels of the antibiotic. Nevertheless, the results obtained allowed the proposal of the following tentative criteria for the interpretation of inhibition zones. Pseudomonadaceae yielding zones of inhibition measuring at least 10 and 16 mm in diameter around 25-and 100-μg discs, respectively, are sensitive to this antibiotic when examined by the standardized Bauer-Kirby method of disc susceptibility testing. Isolates characterized by zones of less than 100 mm in diameter around 25-μg discs should be tested with 100-μg discs before they are reported as sensitive or resistant to carbenicillin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Acred P., Brown D. M., Knudsen E. T., Rolinson G. N., Sutherland R. New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature. 1967 Jul 1;215(5096):25–30. doi: 10.1038/215025a0. [DOI] [PubMed] [Google Scholar]
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Blasius C., Menz H. P., Sander J. Bakteriologische Untersuchungen mit Carbenicillin. Dtsch Med Wochenschr. 1969 Nov 28;94(48):2501–2504. doi: 10.1055/s-0028-1110471. [DOI] [PubMed] [Google Scholar]
- Bodey G. P., Terrell L. M. In vitro activity of carbenicillin against gram-negative bacilli. J Bacteriol. 1968 May;95(5):1587–1590. doi: 10.1128/jb.95.5.1587-1590.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- English Laboratory studies with carbenicillin. Antimicrob Agents Chemother (Bethesda) 1968;8:482–488. [PubMed] [Google Scholar]
- Isenberg H. D., Siegel M. In vitro action of carbenicillin against bacteria isolated from clinical material. Appl Microbiol. 1969 Sep;18(3):387–392. doi: 10.1128/am.18.3.387-392.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Knudsen E. T., Rolinson G. N., Sutherland R. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea. Br Med J. 1967 Jul 8;3(5557):75–78. doi: 10.1136/bmj.3.5557.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers B. R., Sabbaj J., Weinstein L. Bacteriological, pharmacological, and clinical studies of carbenicillin. Arch Intern Med. 1970 Feb;125(2):282–286. [PubMed] [Google Scholar]
- Phair J. P., Watanakunakorn C., Bannister T. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Appl Microbiol. 1969 Sep;18(3):303–306. doi: 10.1128/am.18.3.303-306.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson O. P. Human pharmacology of carbenicillin, a semisynthetic penicillin active against Pseudomonas aeruginosa. Antimicrob Agents Chemother (Bethesda) 1967;7:614–618. doi: 10.1128/AAC.7.5.614. [DOI] [PubMed] [Google Scholar]
- Rolinson G. N., Sutherland R. Carbenicillin, a new semisynthetic penicillin active against Pseudomonas aeruginosa. Antimicrob Agents Chemother (Bethesda) 1967;7:609–613. [PubMed] [Google Scholar]
- Silverblatt F., Turck M. Laboratory and clinical evaluation of carbenicillin (carboxybenzyl penicillin). Antimicrob Agents Chemother (Bethesda) 1968;8:279–285. [PubMed] [Google Scholar]
- Standiford H. C., Kind A. C., Kirby W. M. Laboratory and clinical studies of carbenicillin against gram-negative bacilli. Antimicrob Agents Chemother (Bethesda) 1968;8:286–291. [PubMed] [Google Scholar]